--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About MDGL20260220C560
Biological Technology
Madrigal Pharmaceuticals, Inc., was established in March 2000 and began operations in July 2001.
Synta Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecule drugs to expand and enhance the lives of patients with serious diseases, including cancer and chronic diseases. The company has two drug candidates in clinical trials for the treatment of various types of cancer and several drug candidates in the preclinical research phase. All of the company's drug candidates are discovered using the company's patents, unique compounds and integrated discovery engines. The company retains all options on its drug candidates.
